Eczema social impact: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 3: Line 3:


==Overview==
==Overview==
The [[quality of life]] of patients suffering from [[eczema]] can be tremendously affected, as the [[pruritus]] and consequent scratching can bring about [[sleep disturbance]], daytime [[fatigue]], [[attention-deficit/hyperactivity disorder]], [[headaches]], and [[stunted growth]]. Ultimately, patients could develop poor [[self-esteem]], [[embarrassment]], [[suicidal ideation]], and hence, an overall reduced social life.<ref name="pmid17498413">{{cite journal| author=Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group| title=A population-based survey of eczema prevalence in the United States. | journal=Dermatitis | year= 2007 | volume= 18 | issue= 2 | pages= 82-91 | pmid=17498413 | doi=10.2310/6620.2007.06034 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17498413  }} </ref>  
Pruritus and constant scratching of the skin can significantly affect the social life of patient. Sleep disturbances, attention-deficit/hyperactivity disorder, headaches, daytime fatigue, and stunted growth are commonly seen in these patients and could lead to embarrassment and poor self-esteem. <ref name="pmid17498413">{{cite journal| author=Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group| title=A population-based survey of eczema prevalence in the United States. | journal=Dermatitis | year= 2007 | volume= 18 | issue= 2 | pages= 82-91 | pmid=17498413 | doi=10.2310/6620.2007.06034 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17498413  }} </ref>  
<ref name="pmid17620207">{{cite journal| author=Wittkowski A, Richards HL, Griffiths CE, Main CJ| title=Illness perception in individuals with atopic dermatitis. | journal=Psychol Health Med | year= 2007 | volume= 12 | issue= 4 | pages= 433-44 | pmid=17620207 | doi=10.1080/13548500601073928 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17620207  }} </ref> <ref name="pmiddoi: 10.1111/j.1610-0387.2007.06609.x.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1111/j.1610-0387.2007.06609.x. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref> <ref name="pmid21206547">{{cite journal| author=Camfferman D, Kennedy JD, Gold M, Martin AJ, Winwood P, Lushington K| title=Eczema, sleep, and behavior in children. | journal=J Clin Sleep Med | year= 2010 | volume= 6 | issue= 6 | pages= 581-8 | pmid=21206547 | doi= | pmc=3014245 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21206547  }} </ref> <ref name="pmiddoi: 10.1016/j.clindermatol.2011.11.009.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1016/j.clindermatol.2011.11.009. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref> <ref name="pmiddoi: 10.1016/j.jaci.2006.02.031.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1016/j.jaci.2006.02.031. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref>
<ref name="pmid17620207">{{cite journal| author=Wittkowski A, Richards HL, Griffiths CE, Main CJ| title=Illness perception in individuals with atopic dermatitis. | journal=Psychol Health Med | year= 2007 | volume= 12 | issue= 4 | pages= 433-44 | pmid=17620207 | doi=10.1080/13548500601073928 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17620207  }} </ref> <ref name="pmiddoi: 10.1111/j.1610-0387.2007.06609.x.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1111/j.1610-0387.2007.06609.x. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref> <ref name="pmid21206547">{{cite journal| author=Camfferman D, Kennedy JD, Gold M, Martin AJ, Winwood P, Lushington K| title=Eczema, sleep, and behavior in children. | journal=J Clin Sleep Med | year= 2010 | volume= 6 | issue= 6 | pages= 581-8 | pmid=21206547 | doi= | pmc=3014245 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21206547  }} </ref> <ref name="pmiddoi: 10.1016/j.clindermatol.2011.11.009.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1016/j.clindermatol.2011.11.009. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref> <ref name="pmiddoi: 10.1016/j.jaci.2006.02.031.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1016/j.jaci.2006.02.031. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref>


Revision as of 00:07, 26 May 2022

Eczema Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eczema from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Social Impact

Future or Investigational Therapies

Case Studies

Case #1

Eczema On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eczema

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eczema

CDC on Eczema

Eczema in the news

Blogs on Eczema

Directions to Hospitals Treating Eczema

Risk calculators and risk factors for Eczema

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Pruritus and constant scratching of the skin can significantly affect the social life of patient. Sleep disturbances, attention-deficit/hyperactivity disorder, headaches, daytime fatigue, and stunted growth are commonly seen in these patients and could lead to embarrassment and poor self-esteem. [1] [2] [3] [4] [5] [6]

Social Impact

Burden of eczema can have a significant impact on quality of life. The constant itching can bring about:

References

  1. ↑ Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group (2007). "A population-based survey of eczema prevalence in the United States". Dermatitis. 18 (2): 82–91. doi:10.2310/6620.2007.06034. PMID 17498413.
  2. ↑ Wittkowski A, Richards HL, Griffiths CE, Main CJ (2007). "Illness perception in individuals with atopic dermatitis". Psychol Health Med. 12 (4): 433–44. doi:10.1080/13548500601073928. PMID 17620207.
  3. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1111/j.1610-0387.2007.06609.x. doi: 10.1111/j.1610-0387.2007.06609.x. Check |pmid= value (help).
  4. ↑ Camfferman D, Kennedy JD, Gold M, Martin AJ, Winwood P, Lushington K (2010). "Eczema, sleep, and behavior in children". J Clin Sleep Med. 6 (6): 581–8. PMC 3014245. PMID 21206547.
  5. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1016/j.clindermatol.2011.11.009. doi: 10.1016/j.clindermatol.2011.11.009. Check |pmid= value (help).
  6. ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1016/j.jaci.2006.02.031. doi: 10.1016/j.jaci.2006.02.031. Check |pmid= value (help).
Retrieved from "https://www.wikidoc.org/index.php?title=Eczema_social_impact&oldid=1724700"